Back
Eli Lilly and Vs. Royalty Pharma PLC Industry Stock Comparison
Sell
45
LLY
Eli Lilly and
Last Price:
789.27
Seasonality Move:
4.05%
Sell
30
RPRX
Royalty Pharma PLC
Last Price:
24.85
Seasonality Move:
-2.29%
Sell
45
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $789.12. The Score for LLY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $24.84. The Score for RPRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $789.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $24.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.66 | Sell |
| Relative Strength Index (14 RSI): | 44.66 | Sell |
| Chaikin Money Flow: | 1520610 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (757.23 - 821.11) | Sell |
| Bollinger Bands (100): | (800.36 - 929.58) | Sell |
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 28.3 | Sell |
| Chaikin Money Flow: | -1227412 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.56 - 26.48) | Sell |
| Bollinger Bands (100): | (26.35 - 28.35) | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 806.6 | Sell |
| 20-day SMA: | 782.41 | Buy |
| 50-day SMA: | 834.74 | Sell |
| 200-day SMA: | 837.95 | Sell |
| 8-day EMA: | 796.79 | Sell |
| 20-day EMA: | 799.24 | Sell |
| 50-day EMA: | 824.12 | Sell |
| 200-day EMA: | 809.62 | Sell |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.66 | Sell |
| 20-day SMA: | 26.03 | Sell |
| 50-day SMA: | 26.73 | Sell |
| 200-day SMA: | 27.71 | Sell |
| 8-day EMA: | 25.53 | Sell |
| 20-day EMA: | 25.96 | Sell |
| 50-day EMA: | 26.55 | Sell |
| 200-day EMA: | 27.7 | Sell |
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.92 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.87 per share, and an increase next year of $9.46 per share.
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.22 per share.
Eli Lilly and Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Royalty Pharma PLC Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||